Iván Márquez, new president of the Spanish Melanoma Group

The coordinator of the Hereditary Cancer Unit at Gregorio Marañón Hospital assumes the presidency of the scientific association.

Generic image of a medical research document with scientific diagrams and text.
AI

Generic image of a medical research document with scientific diagrams and text.

Iván Márquez, coordinator of the Hereditary Cancer Unit at the Gregorio Marañón Public Hospital in Madrid, has been appointed president of the Spanish Multidisciplinary Melanoma Group (GEM).

The Spanish Multidisciplinary Melanoma Group (GEM) is a scientific association that aims to bring together and coordinate healthcare professionals dedicated to the care of melanoma patients, promoting research to advance the understanding and treatment of this disease.
Márquez's research activity primarily focuses on melanoma, hereditary cancer, brain tumors, and breast cancer, with involvement in Phase I and III clinical trials and as deputy director of the Phase I and Breast Cancer Unit.
In academia, Márquez has collaborated in practical teaching with the Complutense University of Madrid since 2009, is an invited professor in the Immunology Master's program, and teaches in the Expert in Immuno-oncology program at the University of Navarra. He has also co-supervised three doctoral theses.
He is a member of scientific societies such as the Spanish Society of Medical Oncology (SEOM), the American Society of Clinical Oncology (ASCO), the Society for Immunotherapy of Cancer (SITC), and the "melanoma faculty" of the European Society of Medical Oncology (ESMO). He has authored and co-authored over 80 articles in scientific journals and presented over 100 works at national and international congresses.
This appointment recognizes his exemplary professional career in patient care and research dedicated to melanoma and the development of new therapeutic strategies in oncology.
Based on information from the official source: Comunidad de Madrid — Notas de prensa (05/11/2026)